Lipocine Inc.
LPCN- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001535955
No open-market purchases or sales by Lipocine Inc. insiders were filed in the last 90 days; 36 institutions reported holding it in 13F filings for Q2 2026, worth $7.63M in total; no superinvestor holds it.
Q2 2021 vs. Q1 2021
How the institutions holding Lipocine Inc. changed between Q1 2021 and Q2 2021.
All holders in Q2 2021All holders in Q1 2021
| Measure | Q1 2021 | Q2 2021 | Change |
|---|---|---|---|
| Holders | 42 | 33 | −9 |
| Shares | 8.20M | 9.13M | +928.0K (+11.3%) |
| Value | $12.4M | $12.8M | +$395.9K (+3.2%) |
New holders (5)
Institutions that held Lipocine Inc. at the end of Q2 2021 but not at the end of Q1 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Kestra Advisory Services, LLC | 70,000 | $98.0K | 0.00% |
| Pura Vida Investments, LLC | 54,738 | $77.0K | 0.01% |
| Moloney Securities Asset Management, LLC | 30,000 | $42.0K | 0.01% |
| Principal Financial Group Inc | 20,382 | $29.0K | 0.00% |
| FMR LLC | 2 | $0 | 0.00% |
Sold out (14)
Institutions that held Lipocine Inc. at the end of Q1 2021 and filed for Q2 2021 without it.
| Institution | Shares, Q1 2021 | Value, Q1 2021 |
|---|---|---|
| Virtu Financial LLC | 191,387 | $289.0K |
| Susquehanna International Group, LLP | 143,718 | $217.0K |
| Squarepoint Ops LLC | 84,001 | $127.0K |
| Cubist Systematic Strategies, LLC | 55,200 | $83.0K |
| Group One Trading, L.P. | 51,884 | $78.0K |
| California Public Employees Retirement System | 46,000 | $69.0K |
| Citadel Advisors LLC | 41,772 | $63.0K |
| Jane Street Group, LLC | 29,060 | $44.0K |
| Two Sigma Advisers, LP | 25,900 | $39.0K |
| Qube Research & Technologies Ltd | 23,582 | $36.0K |
| Aaron Wealth Advisors | 15,000 | $22.0K |
| HRT Financial LP | 14,502 | $21.0K |
| Valeo Financial Advisors, LLC | 3,250 | $5.00K |
| Bank of Montreal | 250 | $0 |